Ruane, Cunniff & Goldfarb Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$326M |
| 2 |
Netflix
NFLX
|
+$139M |
| 3 |
Wayfair
W
|
+$105M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$42.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$368M |
| 2 |
UnitedHealth
UNH
|
+$241M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$169M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$107M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$64.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 33.31% |
| 2 | Financials | 23.43% |
| 3 | Healthcare | 15.35% |
| 4 | Technology | 12.43% |
| 5 | Consumer Discretionary | 10.75% |
Similar funds
Ruane, Cunniff & Goldfarb's Q2 2022 Portfolio in Review
As of Q2 2022, Ruane, Cunniff & Goldfarb held 34 positions worth $7.67B, down 24% from $10.2B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Ruane, Cunniff & Goldfarb withdrew a net $462M in Q2 2022, closing 3 positions and reducing 17 holdings. Its most notable exit was Expeditors International, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ruane, Cunniff & Goldfarb added an estimated $326M to Intercontinental Exchange.
- Ruane, Cunniff & Goldfarb added most to Intercontinental Exchange in Q2 2022, an estimated $326M increase.
- Ruane, Cunniff & Goldfarb's biggest Q2 2022 reduction was Elevance Health, cutting an estimated $368M.
- Ruane, Cunniff & Goldfarb fully exited Expeditors International in Q2 2022, selling an estimated $10.5M.
- Ruane, Cunniff & Goldfarb's ten largest holdings make up 70% of its $7.67B portfolio in Q2 2022.
- Ruane, Cunniff & Goldfarb opened 0 new positions and closed 3 in Q2 2022.
- Ruane, Cunniff & Goldfarb's portfolio value fell 24% quarter-over-quarter to $7.67B.
Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2022, filed 15 Aug 2022.